Where does Nina Kjellson work?

Nina Kjellson is General Partner at Canaan Partners and Board director at Annum Health and Board director at Cidara Therapeutics and Board director at Eiger Biopharmaceuticals.

What check size does Nina Kjellson write?

Nina Kjellson typically writes checks of $250K – $20M.

What boards does Nina Kjellson sit on?

Nina Kjellson holds tracked board seats at Annum Health, Cidara Therapeutics, Eiger Biopharmaceuticals, Eiger Biopharmaceuticals, Lycera, TYRA Biosciences, Virgin Pulse, Vitruvian Networks.

Where did Nina Kjellson go to school?

Nina Kjellson studied at Stanford University (BA, Human Biology); Phillips Exeter Academy.

Nina Kjellson

Investor

General Partner at Canaan Partners · Board director at Annum Health · Board director at Cidara Therapeutics · Board director at Eiger Biopharmaceuticals

Menlo Park, California

Writes $250K – $20M checks · typically $10M

Find your path to Nina

619 people in our graph share verified history with Nina — schools, employers, funds. One of them is your warm intro.

Paul KwanunlockedNina: together at Stanford University (1992–1997)

×9Nina: together at Stanford University

Nina: together at Canaan Partners

Nina: together at Blueprint Health LLC

About

Nina Kjellson brings a Nordic perspective to biotech, focusing on therapeutics for serious underserved conditions like addiction and neurological disease, and champions women in healthcare and tech via WoVen podcast

Likely emails· guessed from name + firm domain, not firm-published

n•••@canaan.comreveal100% confident
n•••@canaan.comreveal75% confident

Invests in

BiotechConsumerDeep TechEnterprise SoftwareFintechHardware

Board director at Annum Health

Intro paths

→

In turn, Nina can intro founders to Annum Health's investors below.

Annum Health's investors · 5

.406 VenturesBoston · $1M – $4M checks ARC Angel FundNew York · $50K – $250K checks AXA Venture PartnersNew York Canaan PartnersStamford · $500K – $20M checks · since 2016 Elevate Innovation PartnersNew York

Board director at Cidara Therapeutics

Intro paths

→

In turn, Nina can intro founders to Cidara Therapeutics's investors below.

Cidara Therapeutics's investors · 8

5AM VenturesBoston · $100K – $4M checks · since 2015 Aisling CapitalNew York Bain Capital Life SciencesBoston Canaan PartnersStamford · $500K – $20M checks · since 2015 Frazier Life SciencesPalo Alto · since 2015 RA CapitalBoston Venrock Healthcare Capital PartnersNew York Vivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Cidara Therapeutics

Jeffrey SteinExecutive Officer, Director

Kevin JudiceDirector

Board director at Eiger Biopharmaceuticals

Intro paths

→

In turn, Nina can intro founders to Eiger Biopharmaceuticals's investors below.

Eiger Biopharmaceuticals's investors · 3

Canaan PartnersStamford · $500K – $20M checks · since 2011 Pfizer Venture Investments$5M – $20M checks · since 2015 Vivo CapitalPalo Alto · $10M – $50M checks · since 2016

Experience

Pelican Advisors LLC - Family Office and AdvisoryPartnercurrent2024 — present
Canaan PartnersGeneral Partnercurrent2015 — presentMenlo Park, CA
Actio Biosciences, Inc.Board Membercurrent2023 — present
ProxygenBoard Membercurrent2023 — presentVienna, Austria
Rondo TherapeuticsBoard Membercurrent2022 — present
Trishula Therapeutics, Inc.Board Membercurrent2020 — present
Tizona Therapeutics, Inc.Board Membercurrent2016 — presentSan Francisco Bay Area
Biotechnology Innovation OrganizationBoard Membercurrent2024 — present
Foundation for the National Institutes of HealthBoard Membercurrent2024 — present
The Aspen InstituteHealth Innovators' Fellowcurrent2018 — present
All RaiseMembercurrent2021 — present
Life Science Cares Bay AreaCo-Chair Board of Trustees - nonprofitcurrent2020 — present
Girl EffectBoard Member - nonprofitcurrent2019 — present
WoVen: platform amplifying the ambitions and achievements of women who ventureFoundercurrent2014 — present
Sardona TherapeuticsBoard Member2021 — 2025
Blueprint Health LLCMentor2012 — 2025New York City Metropolitan Area
Blueprint Health LLCMentor2011 — 2015
Tyra BiosciencesBoard Member2020 — 2025
Panacea Acquisition Corp. IIBoard Member2021 — 2023
Essential Access HealthChairwoman - nonprofit2016 — 2023San Francisco Bay Area
PACT PharmaBoard Member2018 — 2022San Francisco Bay Area

Skills & more

Oncology3Business Strategy15Lifesciences36Venture Capital84Private Equity12Biotechnology43Technology Transfer4Investments23M&A experience7Corporate Development36Medical Devices4Pharmaceutical Industry12

+8 more

EntrepreneurshipGo-to-market StrategyVenture FinancingAngel InvestingGrowth CapitalStart-upsDrug DiscoveryBusiness Development

From Nina's professional profile.

Deals · 7

TYRA BiosciencesBoard seat

via Canaan Partners · filed Feb 2024 · $200M raise

Vitruvian NetworksBoard seat

via Canaan Partners · filed Apr 2018 · $33.5M raise

Annum HealthBoard seat

via Canaan Partners · filed Oct 2016 · $2.5M raise

Virgin PulseBoard seat

via Canaan Partners · filed Dec 2015 · $45M raise

LyceraBoard seat

via Canaan Partners · filed Jun 2015

Eiger BiopharmaceuticalsBoard seat

via Canaan Partners · filed Mar 2015 · $14.6M raise

Cidara TherapeuticsBoard seat

via Canaan Partners · filed Feb 2015 · $42M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Canaan Partners

Antonio Lepore

Investor at Canaan Partners

Brendan Dickinson

General Partner at Canaan Partners

Brent Ahrens

General Partner at Canaan Partners

Bridget Flaherty

Director of Primary Labs at Primary Venture Partners

Colleen Cuffaro

Partner at Canaan Partners

Dana Malman Warren

Investor at Canaan Partners

Deepak Kamra

General Partner at Canaan Partners

Evan Teiger

Investor at Canaan Partners

Frequently asked questions

Who is Nina Kjellson?: Nina Kjellson brings a Nordic perspective to biotech, focusing on therapeutics for serious underserved conditions like addiction and neurological disease, and champions women in healthcare and tech via WoVen podcast
Where does Nina Kjellson work?: Nina Kjellson is General Partner at Canaan Partners and Board director at Annum Health and Board director at Cidara Therapeutics and Board director at Eiger Biopharmaceuticals.
What does Nina Kjellson invest in?: Nina Kjellson invests in Biotech, Consumer, Deep Tech, Enterprise Software, Fintech, Hardware.
What check size does Nina Kjellson write?: Nina Kjellson typically writes checks of $250K – $20M.
What boards does Nina Kjellson sit on?: Nina Kjellson holds tracked board seats at Annum Health, Cidara Therapeutics, Eiger Biopharmaceuticals, Eiger Biopharmaceuticals, Lycera, TYRA Biosciences, Virgin Pulse, Vitruvian Networks.
Where did Nina Kjellson go to school?: Nina Kjellson studied at Stanford University (BA, Human Biology); Phillips Exeter Academy.